arrow
P

Paula Jiménez-Fonseca

University of Oviedo
H指数:41
被引数:5,504

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative Chemotherapy and Long-Term Cure in Resected Grade 3 Gastroenteropancreatic Neuroendocrine Carcinomas: The GETNE SOUTH-NEC Study

围手术期化疗与切除后3级胃肠胰神经内分泌癌的长期治愈:GETNE SOUTH-NEC研究

2026-10-080
OAAI
Symptom Burden, Depressive Symptoms, Resilient Coping, and Pretreatment Health-Related Quality of Life with Breast, Gynecological and Genitourinary Cancer

乳腺癌、妇科癌症和泌尿生殖系统癌症的症状负担、抑郁症状、韧性应对及治疗前健康相关生活质量

2026-08-160
OA
Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature

分化良好的神经内分泌肿瘤血液学毒性的综述:病例报告及文献综合回顾

2026-06-170
OA
Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain

西班牙晚期食管胃腺癌患者PD-L1表达的实际情况分析

2026-04-280
OAAI
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis

围术期FLOT疗法是否能提高可切除食管腺癌的治愈率?——混合治愈模型分析

2025-11-260
OAAI
Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registry

肺癌与其他肿瘤的静脉血栓栓塞比较:TESEO-SEOM登记研究的结果

2025-11-030
PRE
External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy

S-GRAS评分在预测肾上腺皮质癌患者复发中的外部验证:对辅助米托坦治疗的启示

2025-08-140
PRE
External validation of a prediction model for bleeding events in anticoagulated cancer patients with venous thromboembolism (PredictAI)

抗凝治疗的静脉血栓栓塞症癌病患者出血事件预测模型(PredictAI)的外部验证

2025-04-260
OA
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer
2025-04-210
OAAI
Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism

卡瓦吉奥评分的推导与验证:癌症相关静脉血栓栓塞症患者复发风险分层的应用

2025-04-180
PRE
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
2025-04-040
OAAI
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

胃肠癌生物标志物2025:西班牙医学肿瘤学会(SEOM)和西班牙病理学会(SEAP)联合发布的最新共识声明

2025-03-120
OA
First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306

一线Tislelizumab联合化疗治疗程序性死亡配体1表达 ≥ 1% 的食管鳞状细胞癌: 原理306的回顾性分析

2025-03-010
OAAI
Does Adjuvant Mitotane Impact Cure Rates in Adrenocortical Carcinoma? Insights From the ICARO-GETTHI/SEEN Registry
2025-02-140
OA